loadpatents
name:-0.032435894012451
name:-0.030548810958862
name:-0.0089020729064941
GEHO; W. BLAIR Patent Filings

GEHO; W. BLAIR

Patent Applications and Registrations

Patent applications and USPTO patent grants for GEHO; W. BLAIR.The latest application filed is for "lipid construct for delivery of insulin to a mammal".

Company Profile
7.30.31
  • GEHO; W. BLAIR - CHAGRIN FALLS OH
  • Geho; W. Blair - Wooster OH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Lipid Construct For Delivery Of Insulin To A Mammal
App 20220110870 - LAU; JOHN R. ;   et al.
2022-04-14
Lipid-based Nanoparticles And Use Of Same In Optimized Insulin Dosing Regimens
App 20210379160 - Geho; W. Blair
2021-12-09
Lipid-based nanoparticles and methods using same
Grant 11,077,173 - Geho August 3, 2
2021-08-03
Lipid-based nanoparticles and methods using same
Grant 11,071,715 - Geho July 27, 2
2021-07-27
Lipid-based Nanoparticles With Enhanced Stability
App 20210137838 - Geho; W. Blair
2021-05-13
Lipid-based nanoparticles and use of same in optimized insulin dosing regimens
Grant 10,918,700 - Geho February 16, 2
2021-02-16
Orally Bioavailable Lipid-based Constructs
App 20200405638 - Lau; John R. ;   et al.
2020-12-31
Compositions Comprising Lipid-based Nanoparticles For Treating Diabetes Mellitus
App 20200375913 - Geho; W. Blair
2020-12-03
Lipid-based Nanoparticles And Methods Using Same
App 20200330560 - Geho; W. Blair
2020-10-22
Lipid-based Nanoparticles And Use Of Same In Optimized Insulin Dosing Regimens
App 20200323961 - Geho; W. Blair
2020-10-15
Orally bioavailable lipid-based constructs
Grant 10,751,418 - Geho , et al. A
2020-08-25
Lipid Construct For Delivery Of Insulin To A Mammal
App 20200261363 - LAU; JOHN R. ;   et al.
2020-08-20
Orally bioavailable lipid-based constructs
Grant 10,568,835 - Lau , et al. Feb
2020-02-25
Lipid-based Nanoparticles And Methods Using Same
App 20200022922 - Geho; W. Blair
2020-01-23
Lipid construct for delivery of insulin to a mammal
Grant 10,463,616 - Lau , et al. No
2019-11-05
Lipid Construct For Delivery Of Insulin To A Mammal
App 20190054021 - LAU; JOHN R. ;   et al.
2019-02-21
Lipid construct for delivery of insulin to a mammal
Grant 10,004,686 - Lau , et al. June 26, 2
2018-06-26
Orally bioavailable lipid-based constructs
Grant 9,943,602 - Geho , et al. April 17, 2
2018-04-17
Orally bioavailable lipid-based constructs
Grant 9,145,453 - Geho , et al. September 29, 2
2015-09-29
Lipid construct for delivery of insulin to a mammal
Grant 9,034,372 - Lau , et al. May 19, 2
2015-05-19
Orally Bioavailable Lipid-based Constructs
App 20150125518 - LAU; JOHN R. ;   et al.
2015-05-07
Orally bioavailable lipid-based constructs
Grant 8,962,015 - Lau , et al. February 24, 2
2015-02-24
Lipid Construct For Delivery Of Insulin To A Mammal
App 20150031608 - LAU; JOHN R. ;   et al.
2015-01-29
Orally bioavailable lipid-based constructs
Grant 8,846,053 - Geho , et al. September 30, 2
2014-09-30
Orally Bioavailable Lipid-based Constructs
App 20140243430 - GEHO; W. BLAIR ;   et al.
2014-08-28
Lipid Construct for Delivery of Insulin to a Mammal
App 20130267462 - Lau; John R. ;   et al.
2013-10-10
Orally Bioavailable Lipid-Based Constructs
App 20130183270 - Geho; W. Blair ;   et al.
2013-07-18
Targeted liposomal drug delivery system
Grant 8,303,983 - Lau , et al. November 6, 2
2012-11-06
Method of increasing the bioavailability of recombinant human insulin isophane in a patient
Grant 8,257,735 - Lau , et al. September 4, 2
2012-09-04
Insulin Therapies for the Treatment of Diabetes, Diabetes Related Ailments, and/or Diseases or Conditions Other Than Diabetes or Diabetes Related Ailments
App 20120035105 - Geho; W. Blair ;   et al.
2012-02-09
Lipid Construct for Delivery of Insulin to a Mammal
App 20110135725 - Lau; John R. ;   et al.
2011-06-09
Hepatocyte Delivery Vehicle for Delivery of a Combination of Recombinant Human Regular Insulin and Recombinant Human Insulin Isophane to a Mammal
App 20110135727 - Lau; John R. ;   et al.
2011-06-09
Hepatocyte-targeting vehicle for delivery of glargine insulin to a mammal
Grant 7,871,641 - Lau , et al. January 18, 2
2011-01-18
Hepatocyte delivery vehicle for delivery of a combination of recombinant human regular insulin and recombinant human insulin isophane to a mammal
Grant 7,858,116 - Lau , et al. December 28, 2
2010-12-28
Orally Bioavailable Lipid-Based Constructs
App 20100310599 - GEHO; W. Blair ;   et al.
2010-12-09
Orally Bioavailable Lipid-Based Constructs
App 20100247625 - Geho; W. Blair ;   et al.
2010-09-30
Targeted Liposomal Drug Delivery System
App 20100209492 - Lau; John R. ;   et al.
2010-08-19
Supra Molecular Construct For Delivery Of Interferon To A Mammal
App 20100129428 - Lau; John R. ;   et al.
2010-05-27
Orally Bioavailable Lipid-Based Constructs
App 20100080773 - Geho; W. Blair ;   et al.
2010-04-01
Orally bioavailable lipid-based constructs
App 20090087479 - Lau; John R. ;   et al.
2009-04-02
Supra molecular construct for delivery of interferon to a mammal
App 20070218117 - Lau; John R. ;   et al.
2007-09-20
Targeted liposomal drug delivery system
App 20070104777 - Lau; John R. ;   et al.
2007-05-10
Targeted liposomal drug delivery system
Grant 7,169,410 - Lau , et al. January 30, 2
2007-01-30
Hepatocyte delivery vehicle for delivery of glargine insulin to a mammal
App 20060222698 - Lau; John R. ;   et al.
2006-10-05
Hepatocyte delivery vehicle for delivery of a combination of recombinant human regular insulin and recombinant human insulin isophane to a mammal
App 20060222697 - Lau; John R. ;   et al.
2006-10-05
Dual therapy method of treating and controlling diabetes mellitus
App 20020177546 - Geho, W. Blair ;   et al.
2002-11-28
Method of preventing and treating the complications of insulin dependent diabetes mellitus
App 20020147134 - Geho, W. Blair ;   et al.
2002-10-10
Prevention or treatment of complications related to non-insulin dependent diabetes mellitus or type 2 diabetes mellitus
App 20020137787 - Geho, W. Blair ;   et al.
2002-09-26
Masking of liposomes from RES recognition
Grant 6,177,099 - Lau , et al. January 23, 2
2001-01-23
Targeted liposomal constructs for diagnostic and therapeutic uses
Grant 6,063,400 - Geho , et al. May 16, 2
2000-05-16
Hair penetrant and carrier
Grant 5,436,010 - Lau , et al. July 25, 1
1995-07-25
Diabetic control by combined insulin forms
Grant 4,863,896 - Geho , et al. September 5, 1
1989-09-05
Gelcores
Grant 4,740,375 - Geho , et al. April 26, 1
1988-04-26
Antitoxin vaginal products and catamenials
Grant 4,722,937 - Jacob , et al. * February 2, 1
1988-02-02
Treatment for hyperactivity
Grant 4,704,394 - Geho November 3, 1
1987-11-03
Hepatocyte Directed Vesicle delivery system
Grant 4,603,044 - Geho , et al. July 29, 1
1986-07-29
Treatment for hypoglycemia
Grant 4,602,043 - Geho July 22, 1
1986-07-22
Masking of liposomes from RES recognition
Grant 4,501,728 - Geho , et al. February 26, 1
1985-02-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed